Les publications de Thomas RAPP
- Are frail elderly people in Europe high-need subjects? First evidence from the SPRINTT trial
- The Dynamics of Frailty and Change in Socio-Economic Conditions: Evidence for the 65+ in Europe
- Frailty transitions and healthcare use in Europe. New evidence from SHARE data
- The impact of economic conditions on the disablement process: A Markov transition approach using SHARE data
- The Cost of Frailty in France
- The Dynamics of Hospital Use among Older People. Evidence for Europe using SHARE data
- The impact of institution use on the wellbeing of Alzheimer’s disease patients and their caregivers
- Quality of diabetes follow-up care and hospital admissions forthcoming
- Resource use and cost of Alzheimer’s disease in France: 18-month results from the GERAS observational study
- The impact of material conditions on the disablement process (Forthcoming)
- Genèse, bilan et futur de l’ObamaCare (forthcoming)
- La maladie d’Alzheimer, une affaire de famille
- Preventing frailty and autonomy loss in Europe: A health economics perspective from the SPRINTT study
- L’évaluation HTA simplifiée : perspectives pour la France
- The Dynamics of Hospital Use among Older People Evidence for Europe Using SHARE Data
- Exploring the determinants of endocrinologist visits by patients with diabetes
- Vieillissement, fragilité et dépenses de santé
- Effects of a long-term exercise program on functional ability in people with dementia living in nursing homes : Research protocol of the LEDEN study, a cluster randomised controlled trial
- The cost of frailty in France
- Les innovations « frugales », source de valeur pour nos systèmes de santé ?
- Dépenses de santé, vieillissement et fragilité : le cas français
- L’aide publique aux personnes âgées fragiles en situation de précarité financière : comparaison franco-américaine
- L’intégration des parcours de soins aux Etats-Unis : quels constats cinq ans après le lancement de l’ObamaCare ?
- Are public subsidies effective to reduce emergency care use ? Evidence from the PLASA study, Social Science and Medicine.
- An analysis of the public financial support eligibility rule for French dependent elders with Alzheimer’s disease, Value in Health.
- Preventing frailty and autonomy loss in Europe: A health economics perspective from the SPRINTT study, Aging Clinical and Experimental Research, Special Issue on frailty
- La fragilité : aspects économiques, in Repérage et maintien de l’autonomie des personnes âgées fragiles
- Patients’ diagnosis decisions in Alzheimer’s disease : The influence of family factors
- Health Economics Considerations in Neurodegenerative Disorders
- Comparison of informal care time and costs in different age-related dementias : a review, Accepted for publication, Journal of biomedicine and biotechnology
- Methodological considerations in Cost of Illness Studies on Alzheimer Disease
- Exploring the Relationship Between Alzheimer’s Disease Severity and Longitudinal Costs
- Public financial support receipt and non-medical resource utilization in Alzheimer’s disease -Results from the PLASA study
- Differences in Resource Use and Costs of Dementia Care Between European Countries : Baseline Data from the ICTUS Study
- Health Economics and Health Policy Issues in Alzheimer’s Disease
Back to Top
